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Abstract: An exhaustive exploration into the metabolic content of the Mediterranean 
sponge Axinella-polypoides resulted in the isolation of the new betaine 5 and the new 
cyclonucleoside 8. The structures of the new metabolites were elucidated by spectroscopic 
methods assisted by computational methods. The analysis also provided evidence that the 
sponge does not elaborate pyrrole-imidazole alkaloids (PIAs) but, interestingly, it was 
shown to contain two already known cyclodipeptides, compounds 9 (verpacamide A) and 10.  
Keywords: natural products; sponges; Axinellidae; pyrrole-imidazole alkaloids;  
taxon-specificity 
 
1. Introduction 
Diverse natural products found within sponges mediate many of their ecological interactions, 
including defense against predators and fouling organisms. Marine sponges of genus Axinella are an 
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interesting target for chemo-ecological investigations. They are a well-known source of  
pyrrole-imidazole alkaloids (PIAs), which have been found only in the marine environment to date. 
Historically, this family of alkaloids has attracted the attention of natural product chemists because of 
their structural complexity and pharmacological activity; their role in chemically mediated interactions 
of Caribbean sponges has also been proven [1,2]. In addition, the systematic recurrence of PIAs in 
Axinellidae sponges, as well as in Agelasidae, allowed for speculation as to their taxon-specificity and 
consideration of these secondary metabolites as chemical markers for phylogenetically related sponges [3]. 
However, the setting up of a chemical “fingerprint” of a sponge, collected from different ecosystems, 
requires exhaustive chemical studies. An illustrative example is the sponge Axinella polypoides 
(Schmidt 1862), widely distributed in the rock reefs of the Mediterranean Sea. Early studies are 
reported in literature on the chemistry of this sponge, mainly concerning its steroid and lectin  
content [4–8]; actually, recent re-examinations of samples of A. polypoides, coming from different 
Mediterranean areas, demonstrated that the sponge has an efficient biosynthetic potential, revealing a 
great variety and abundance of secondary metabolites, some of them being new molecules (Figure 1). 
In detail, two new modified amino acids, axiphenylalaninium (1) and axityrosinium (2), were found in 
specimens of the sponge collected off Marseille city [9] along with the known metabolites  
C
2
-α-D-mannopyranolsyl-L-tryptophan (6) [9,10–12], palythine (4) [9,13,14], N3,5′-cycloxanthosine  
(7) [9,11,15], and taurine [9,16]; no data was reported on the presence of PIAs in the sponge. 
Successively, during our ongoing search for new bioactive alkaloids from Axinellidae sponges, we 
have isolated compounds 1 and 2 in specimens of A. polypoides collected along Corsican coasts, 
together with a new betaine, polyaxibetaine (3) [17]. 
Figure 1. Secondary metabolites isolated from A. polypoides. 
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In the present communication we describe the results obtained from a further and more exhaustive 
exploration into the metabolic content of a larger sample of A. polypoides, which resulted in the 
isolation of a new pyridinium derivative, compound 5, and the new cyclonucleoside 8. All the 
previously reported secondary metabolites from the sponge were re-isolated, except for palythine (4). 
We did not find any member of the PIAs family in the sponge extract but, interestingly, it was shown 
to contain the already known cyclodipeptides 9 (verpacamide A) and 10. The cyclo(L-Arg-D-Pro) 
dipeptide 10 was first isolated from a marine bacterium, Pseudomonas sp. IZ208 [18]; the relevant 
cyclo(L-Arg-L-Pro) stereoisomer, verpacamide A (9), was first reported as a natural metabolite of the 
sponge Axinella vaceleti along with the analogues verpacamides B–D and these metabolites were 
considered as possible precursors of PIAs [19]. 
2. Results and Discussion 
Specimens of A. polypoides were collected in the bay of Calvi (Corsica, France), they were 
immediately frozen after collection, and kept at −20 °C until extraction. For the extraction, fresh 
thawed tissues of the sponge were homogenized and exhaustively extracted at room temperature with 
MeOH and CHCl3 successively. The extracts were combined and concentrated; the resulting aqueous 
suspension was then partitioned between butanol and H2O. Both organic and aqueous layers were 
fractionated by MPLC over a reversed-phase C-18 column and by DCCC, respectively. All the 
fractions thus obtained were subjected to a combined NMR/ESIMS-based monitoring for the rapid 
identification of PIAs, also exploiting, as reference compounds, the copious chemical library of these 
alkaloids available in our laboratories. None of the already described PIAs was detected; fractions of 
interest were separated by repeated HPLC, resulting in the isolation of pure compounds 1–3 and 5–10. 
Taurine, as well as compounds 1–3, 6, 7, 9, and 10 were readily identified by comparison of their 
spectroscopic data with those reported in literature [9–17], while the structures of the new compounds 
5 and 8 were established as follows. 
HRESI mass spectrum (positive ions) of 5 revealed two pseudomolecular ion peaks at m/z 210.1130 
and 232.0950, corresponding to [M + H]
+
 (calculated value: 210.1125), and [M + Na]
+
 (calculated 
value: 232.0944), respectively. The molecular formula C11H15NO3 was thus established for 5, 
indicating five unsaturation degrees. 
1
H-NMR spectrum of 5 (CD3OD), interpreted on the basis of 2D 
experiments (HSQC, COSY) contained a set of aromatic signals, each integrating for one proton; the 
chemical shift and coupling constants values of these signals [δ 9.10 (bs, δC = 148.7, H-2); 8.84  
(bd, J = 8.2 Hz, δC = 146.3, H-4); 8.19 (d, J = 8.2 Hz, δC = 126.6, H-5)] were strongly indicative of a  
1,2,5-trisubstituted pyridinium ring. Further proton resonances were a deshielded methine at δ 5.13 
(dd, J = 9.0, 3.3 Hz, δC = 69.3, H-1′), two AB methilene systems at δ 1.72/1.81 (δC = 38.9, 2H-2′) and 
1.54/1.63 (δC = 19.9, 2H-3′), as well as a methyl resonating as a triplet at δ 1.00 (J = 7.5 Hz, δC = 14.0, 
3H-4′), which were arranged in a single spin system on the basis of COSY connectivities. The signal at 
δ 5.13 was correlated in the HSQC spectrum with a signal at δ 69.3 attributable to an oxygen bearing 
carbon, thus evidencing a 1-hydroxybutyl unit.  
An N-methyl signal δ 4.38 (δC = 46.1) was also present in the proton spectrum of 5; it was 
correlated in the ROESY spectrum (CD3OD) with the aromatic proton singlet at δ 9.10 (H-2) and with 
the oxymethine proton at δ 5.13 (H-1′). This latter information, according to the coupling constants 
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pattern of the aromatic signals, provided convincing evidence for an N-methyl-2,5-disubstituted 
pyridinium ring and indicated that the 1-hydroxybutyl unit must be linked at one of the N-flanking 
carbons. Diagnostic C–H long range couplings, evidenced by HMBC map (CD3OD, see Table 1), 
substantiated the proposed structural features and allowed to identify the third substituent, obviously 
liked at C-3.  
Table 1. NMR data (CD3OD) of compound 5. 
Position δH (mult., J in Hz) δC HMBC 
1-NMe 4.38 (s) 46.1 2, 6 
2 9.10 (bs) 148.7 1-NMe, 4, 6, COO
-
 
3 - 137.8 - 
4 8.84 (bd, 8.2) 146.3 2, 6, COO
−
Na
+
 
5 8.19 (d, 8.2) 126.6 3, 6, 1′ 
6 - 163.0 - 
1′ 5.13 (dd, 3.3, 9.0) 69.3 6, 2′ 
2′ 
1.72 (m) 
1.81(m) 
38.9 6, 1′, 3′, 4′ 
3′ 
1.54 (m) 
1.63 (m) 
19.9 1′, 2′, 4′ 
4′ 1.00 (t, 7.5) 14.0 2′, 3′ 
–COO- - 167.0 - 
Particularly, the N-methyl signal at δ 4.38 was correlated to the carbon at δ 148.7 (C-2) and a 
quaternary carbon at δ 163.0 (C-6) which, in turn, was coupled to the signal at δ 5.13 (H-1′) and  
8.19 (H-5); the latter signal was correlated with the oxymethine carbon at δ 69.3 (C-1′) and the 
quaternary carbons at δ 163.0 (C-6) and 137.8 (C-3). Moreover, both aromatic signals at δ 9.10 (H-2) 
and 8.84 (H-4) were coupled to a low-field carbon resonance at δ 167.0, attributable to a carbonyl; this 
datum, according to the mass data, allowed to locate a carboxylate function at C-3, thus accounting for 
the last unsaturation degree indicated by the molecular formula. Therefore, the planar structure of 
compound 5 was unambiguously defined as 6-(1-hydroxybutyl)-1-methylpyridinium-3-carboxylate. 
Absolute configuration (AC) of compound 5 was established with the help of electronic circular 
dichroism (ECD) spectroscopy assisted by quantum mechanical calculations. The application of  
ab initio time-dependent density functional theory (TDDFT) to the calculation of ECD spectra has 
greatly enhanced the reliability with which they can be predicted and, thus, this methodology is being 
increasingly utilized in determining ACs of natural products [17,20–22]. The experimental ECD 
spectrum of 5 was virtually compared to that predicted by TDDFT calculations for one of the two 
enantiomers. In detail, an initial conformational analysis of the S stereoisomer was performed, using 
the Simulated Annealing procedure (INSIGHT II Software Package). The resulting conformers were 
ranked on the basis of their conformational energy values and grouped into families. Twelve minima 
for S-5 were obtained and all conformers were optimized with the software package Gaussian 03 [23] 
by using DFT at the RB3LYP/6-31G(d) level (the conformational families of S-5, as well as their 
resulting relative (∆E) and free (∆G) energies, are provided as Supporting Information). For all 
conformers of S-5, the excitation energies, as well as the oscillator and rotatory strengths of the 
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electronic excitation were calculated, using the TDDFT methodology at the RB3LYP/6-31G(d,p) 
level; their ECD spectra were then simulated by the overlapping Gaussian function. To obtain the final 
ECD spectrum of each compound, the simulated spectra of the lowest energy conformations were 
averaged, by following the Boltzmann statistic, and were UV corrected. The theoretical curve was then 
compared to the experimental spectrum of compound 5, recorded in MeOH. As shown in Figure 2, the 
agreement between the simulated and experimental ECD spectra of 5 was very satisfactory and, thus, 
the absolute configuration of 1 was established as S.  
Figure 2. Theoretical CD curve (
__
) of S-5 model vs. experimental curve (
__
) of compound 5. 
 
A pseudomolecular peak was present in the HRESI mass spectrum (positive ions) of 8 at  
m/z 283.0673 [M + H]
+
 (calculated value: 283.0679), thus supporting the molecular formula 
C10H10N4O6. 
1
H-and 
13
C-NMR spectral data of 8 strongly resembled those of the known 
cyclonucleoside 7 (see Table 2). The proton spectrum of 8 (d6-DMSO) contained indeed resonances 
relevant to a sugar moiety which were nearly identical to those of 7, with regard to the number and 
shape of the signals (see Table 2); the striking difference was confined to the chemical shift value of 
the anomeric proton (H-1′, δ 5.67 in 8 versus 6.15 in 7). As for the heterocyclic moiety, the 1H-NMR 
spectrum of 8 lacked the signal due to the single aromatic proton of xanthosine present in that of 7 at  
δ 7.79 but a further exchangeable proton at δ 11.2 (NH-7) was present. On the other hand, 13C-NMR 
spectrum (d6-DMSO), interpreted also on the basis of the HSQC experiment, contained a further 
deshielded quaternary carbon resonance at δ 149.6 instead of the C-8 methine carbon resonating at δ 
134.5 in the 
13
C-NMR spectrum of 7. All these findings indicated the 8-oxo-N
3
,5-cycloxanthosine 
structure for compound 8, according to MS data and HMBC correlations (see Table 2).  
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Table 2. NMR data (d6-DMSO) of compounds 7 and 8. 
Position 
7 8 
δC δH (J in Hz) δC δH (J in Hz) HMBC 
a 
1 - - - - - 
2 151.0 - 150.7 - - 
3 - - - - - 
4 140.7 - 136.8 - - 
5 117.8 - 98.8 - - 
6 157.4 - 153.4 - - 
7 - - - - - 
8 134.5 7.79 (s) 149.6 - - 
9 - - - - - 
1′ 92.5 6.15 (s) 91.1 5.67 (s) 4, 8, 2′, 3′, 4′ 
2′ 75.8 3.87 (dd, 5.2, 5.0) 75.0 3.90 (t, 5.3) 1′, 4′ 
3′ 70.1 4.20 (m) 70.7 4.23 (m) 5′ 
4′ 83.7 4.55 (m) 83.6 4.46 (m) - 
5′a 51.3 4.56 (m) 52.3 
4.51 (dd, 14.4, 
2.4) 
2, 4, 3′, 4′ 
5′b 51.3 3.71 (dd, 15.2, 3.2) 52.3 3.72 (dd,14.4, 2.8) 2, 4, 3′, 4′ 
OH-2′ - 5.62 (d, 5.0) - 5.60 (d, 5.3) - 
OH-3′ - 5.62 (bs) - 5.35 (d, 7.1) - 
NH-1 - 11.2 - 11.3 5, 6 
NH-7 - - - 11.2 4, 5, 8 
a
 HMBC correlations are from proton(s) stated to the indicated carbon. 
3. Experimental Section  
3.1. General Experimental Procedures 
HRESIMS (positive mode) were performed on a Thermo LTQ Orbitrap XL mass spectrometer. The 
spectra were recorded by infusion into the ESI source using MeOH as the solvent. Optical rotations 
were measured with a Perkin-Elmer 192 polarimeter at 589 nm using a 10 cm microcell. ECD spectra 
were recorded on an J-710 spectropolarimeter (Jasco, Tokyo, Japan) equipped with a J-710 for 
Windows software (Jasco). 
1
H (700 MHz and 500 MHz) and 
13
C (175 MHz and 125 MHz) NMR 
spectra were recorded on a Varian INOVA spectrometer; chemical shifts were referenced to the 
residual solvent signal (CD3OD: δH = 3.31, δC = 49.0; d6-DMSO: δH = 2.50, δC = 39.0). Homonuclear 
1
H connectivities were determined by COSY experiments. Through-space 
1
H connectivities were 
evidenced using a ROESY experiments with a mixing time of 500 ms. Two and three bond 
1
H-
13
C 
connectivities were determined by gradient 2D HMBC experiments optimized for a 
2,3
J of 8 Hz. 
3.2. Collection, Extraction and Isolation 
Specimens of A. polypoides were collected in the Bay of Calvi (Corsica, France), frozen 
immediately and kept frozen until extraction. A reference specimen was deposited at the Dipartimento 
di Chimica delle Sostanze Naturali, University of Naples “Federico II”. Fresh thawed animals (105.2 g 
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dry weight after extraction) were homogenized and extracted twice with MeOH and, then, twice with 
CHCl3 (4 × 500 mL). Extracts were combined and concentrated; the resulting aqueous residue was 
then partitioned between H2O and n-BuOH. Separation of the organic phase (13.0 g) was achieved by 
reversed-phase silica gel (RP18) MPLC, using a gradient elution (H2O→MeOH→CHCl3). Ten 
fractions (A–L) were obtained, each of them was subjected to a rapid 1H-NMR/ESIMS-based analysis. 
Fraction B, eluted with H2O/MeOH 9:1 v/v, (3.4 g) was re-chromatographed under medium pressure 
on a RP18 column eluting with a linear gradient of MeOH (from 2% to 100%) in H2O, thus affording 
twelve fractions (1–12). Fraction 8 (219 mg), eluted with H2O/MeOH 92:8 v/v, was separated by 
HPLC on a Synergy Polar-RP 4 μm column (250 × 4.60 mm) eluting with H2O/MeOH (98:2, v/v) and 
0.1% TFA, to give compounds 7 (22.3 mg) and 8 (4.0 mg). Fraction 10 (55.8 mg), eluted with 
H2O/MeOH (85:15, v/v) was separated by HPLC in the same conditions as above, to give 9 (7.8 mg) 
and 10 (4.8 mg). Fractions C and D, both eluted with H2O/MeOH 7:3 v/v, were combined (524.5 mg) 
separated by HPLC on a Synergy Polar-RP 4 μm column (250 × 4.60 mm) eluting with H2O/MeOH 
(98:2, v/v), to give axityrosinium (1, 52.0 mg), axiphenylalaninium (2, 19.2 mg), polyaxibetaine  
(3, 6.0 mg) and compound 6 (9.1 mg). 
The hydrophilic extract (42.7 g) was subjected to Droplet Counter Current Chromatography 
(DCCC), using a mixture of BuOH-Acetone-H2O (3:1:5) as the solvent, in the ascending mode. The 
flow rate of the mobile phase was adjusted to 25 mL/h; a total of 150 fractions of 8 mL each were 
collected and, as for the organic extract, analyzed by 
1
H-NMR/ESIMS for the rapid detection of PIAs. 
Fractions 40–50 were combined, the solvent was evaporated, and the residue (300 mg) was 
chromatographed by HPLC on a Synergy Polar-RP 4 μm column (250 × 4.60 mm) eluting with 
H2O/MeOH (98:2, v/v) and 0.1% TFA, thus affording pure 5 (16.4 mg). 
Compound 5: [α]D +7.59 (MeOH, c = 0.005; HRESI-MS (positive ion mode): m/z = 210.1130  
[M + H]
+
, 232.0950 [M + Na]
+
; 
1
H and 
13
C NMR data (CD3OD) are reported in Table 1.  
Compound 8: [α]D +1.70 (MeOH, c = 0.003); HRESI-MS (positive ion mode): m/z = 283.0673  
[M + H]
+
, 265.0567 [M − H2O + H]
+
; 
1
H and 
13
C NMR data (d6-DMSO) are reported in Table 2. 
3.3. Computational Details 
A preliminary conformational search for one of the two enantiomers of 5 was performed by 
Simulated Annealing in the INSIGHT II package. The MeOH solution phases were mimicked through 
the value of the corresponding dielectric constant. Using the steepest descent followed by  
quasi-Newton-Raphson method (VA09A) the conformational energy was minimized. Restrained 
simulations were carried out for 500 ps using the CVFF force field as implemented in Discover 
software (Accelrys, San Diego, USA). The simulation started at 1000 K, and then the temperature was 
decreased stepwise to 300 K. The final step was again the energy minimization, performed in order to 
refine the structures obtained, using the steepest descent and the quasi-Newton-Raphson (VA09A) 
algorithms successively. Both dynamic and mechanic calculations were carried out by using  
1 (kcal/mol)/Å 2 flat well distance restraints. One hundred structures were generated. To simulate the 
solvent chosen for NMR analysis, a distance-dependent dielectric constant set to the value of MeOH  
(ε 32.63) was used during the calculations. All optimizations were performed with the software 
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package Gaussian 03, by using the DFT functional RB3LYP and the basis set 6-31G(d). The 
B3LYP/6-31G(d) harmonic vibrational frequencies were further calculated to confirm their stability. 
Rotatory strength values for the electronic transitions from the ground state to the singly excited states 
for all conformers of S-5 were obtained by TDDFT calculations RB3LYP/6-31G(d,p) with Gaussian 03. 
The rotatory strength values were summed after a Boltzmann statistical weighting and ∆ε values were 
calculated by forming sums of Gaussian functions centered at the wavelengths of the respective 
electronic transitions and multiplied by the corresponding rotatory strengths. The ECD spectra that was 
obtained was UV-corrected and compared with the experimental one. 
4. Conclusions  
While highlighting the uncommon chemodiversity of A. polypoides, these results pointed out that 
the sponge does not elaborate PIAs. This finding is in agreement with the results of a recent 
investigation on the chemical defense of A. polypoides and the co-occurring species A. verrrucosa, 
against microbial fouling and in feeding deterrence of a potential predator [24], activities which are 
believed to be mediated by PIAs [1,2]. This study indicated in A. polypoides neither chemical defense 
against microbial fouling nor chemically mediated feeding deterrence activity. In contrast, the 
sympatric sponge A. verrucosa has a chemical defense which, as in many other species of the genera 
Axinella and Agelas, is mediated by its bromopyrrole compounds [25–27], such as hymenidin, which 
exhibits multiple defensive roles [24]. Recent studies have reported on the phylogenetic status of the 
genus Axinella [28], which is difficult to define on the basis of its morphological character and 
includes a heterogeneous assemblage of species. A new phylogenetic hypothesis of Axinellidae and 
Axinella, based on two independent molecular markers (18S and 28S rRNA), has been proposed. In 
this taxonomic reconstruction, A. polypoides and A. vaceleti belong to a distinct clade (Axinellidae
P
) 
than Axinella verrucosa; this latter sponge is now included in a new clade, named Cymbaxinella
P
, 
which could be interpreted also as a new genus. The new clade Cymbaxinella
P
 constitutes a well 
supported clade sister-group to Agelas
P
, according to the chemotaxonomic hypothesis proposed by 
Braekman et al. [29] on the basis of the presence of pyrroles. The clades Agelas
P
 and Cymbaxinella
P
 
constitute a new clade: Agelasida
P
. Our results, thus, provide a chemotaxonomic support for the above 
mentioned molecular analysis, demonstrating that A. polypoides does not contain pyrroles, whereas it 
shares with A. vaceleti the presence of diketopiperazine derivatives.  
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